Afzal Khan

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited, Eisai R & D Development Co., Ltd.. Active years: 2008-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Afzal Khan. Retrieved from https://idiyas.com/inventor/afzal-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 35.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 139(Granted Patents)

Location History:

London, GB (2008 - 2015)
Hertfordshire, GB (2018)

Company Filing History:

12 out of 530

Eisai R&d Management Co., Ltd.

patents

1 out of 677

Eisai Company, Limited

patents

1 out of 1

Eisai R & D Development Co., Ltd.

patent

Years Active: 2008-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10072005 - 4-azaindole derivatives (2018-09-11),

2. 9926312 - 4-azaindole derivatives (2018-03-27),

3. 8946211 - Fused aminodihydrothiazine derivatives (2015-02-03),

4. 8946210 - Fused aminodihydrothiazine derivatives (2015-02-03),

5. 8501733 - Spiroaminodihydrothiazine derivatives (2013-08-06),

6. 8178552 - 7-Azaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase (2012-05-15),

7. 8158620 - Fused aminodihydrothiazine derivatives (2012-04-17),

8. 7951802 - Use of 7-azaindoles in the inhibition of c-Jun N-terminal kinase (2011-05-31),

9. 7652137 - Synthesis of 5 substituted 7-azaindoles and 7-azaindolines (2010-01-26),

10. 7645769 - Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation (2010-01-12),

11. 7612086 - JNK inhibitors (2009-11-03),

12. 7534800 - 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders (2009-05-19),

13. 7432375 - JNK inhibitors (2008-10-07),

14. 7314940 - Jun kinase inhibitors (2008-01-01),

Title: Inventor Afzal Khan: Revolutionizing Technology in London

Introduction: Afzal Khan, a visionary inventor based in London, GB, is renowned for his groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, Khan has made significant strides in the world of patents and inventions.

Latest Patents: Khan's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and sustainable urban development solutions. His innovative approach to problem-solving has led to the creation of patents that are shaping the future of various industries.

Career Highlights: Throughout his illustrious career, Afzal Khan has received numerous accolades for his inventive spirit and dedication to pushing the boundaries of technology. His patents have not only revolutionized existing processes but have also paved the way for new possibilities in the tech world.

Collaborations: Khan has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with diverse teams and experts has been instrumental in the success of his patented innovations.

Conclusion: In conclusion, Afzal Khan stands as a beacon of innovation in London, GB, inspiring the next generation of inventors to think outside the box and pursue their creative visions. His contributions to the world of patents and inventions continue to leave a lasting impact on society.

Profile summary based on public USPTO records.